Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This change does not affect the study data or content presented.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0. No study content or user-facing information appears to have changed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3, indicating an administrative update to the page version.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.2 was added and the government-funding notice along with the prior revision entry v3.4.1 were removed; these are minor boilerplate updates that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedAdded a site-wide funding/status notice indicating government funding issues and ongoing operations; Updated the page revision from v3.4.0 to v3.4.1. These changes are minor and do not affect study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a glossary toggle to the page. Updated metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and bumped the revision to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.